dissenting diseases

(Nasdaq:REGN) will webcast its presentation at
the Fourth Annual Needham Biotechnology Conference on Wednesday, May
25, 2005.

dissenting allergies

Further
management discussions of risks and uncertainties can be found in the
company's quarterly filings with the Securities Exchange Commission. Eastern Time. The session may be accessed through the Company's
website (www. An archived
version of the presentation will be available after the live webcast
through June 24, 2005.

disease controversies

Sites listed in this category focus on the controversies surrounding specific diseases and treatments.

wounds criticisms

"

ALR, a leader in disease management compliance and telehealth, has designed
and manufactures compliance reminder products and compliance
home-monitoring and intervention systems to meet the needs for several
targeted user groups.

This release contains certain "forward-looking statements" relating to ALR
Tech 's business, and these statements reflect the current views of ALR Tech
with respect to future events and are subject to certain risks,
uncertainties and assumptions.

ulcers controversial

When used, the words "optimistic ,"
"projections," "plan to," "estimate," "expect," "anticipate," "believe"
and similar expressions are intended to identify such forward-looking
statements.

dissenting asthma

Sidney Chan, Chairman and Chief Executive of ALR, states, "Without
compliance the patient does not receive the intended benefit of treatments
and medications, and millions of people are noncompliant with disease
management activities. Given our development progress and ongoing
discussions and negotiations with prospective customers, we are optimistic
about our sales and earnings projections for 2006.Y.com on the Events page, under the Investor
Relations heading) at the time of the presentation.

Sites about the condition or disease itself, or living with it, or about conventional, non-controversial, treatments, should go in Health/Conditions_and_Diseases - this category is for non-conventional understandings, criticisms , and dissenting views.

trachoma ulcers

The company also
announced they are moving forward on their plans to add diagnostic
monitoring to their home monitoring system. This will enable medical
personnel or other caregivers to remotely monitor on a daily basis such key
data as blood pressure, blood glucose , heart rate and use of nebulizer
compressors.

dissenting sexually

More information on ALR
Technologies and its products can be found at www.com.

ulcers hypothermia

There are many factors that could cause the actual results,
performance or achievements of ALR Tech and its products to be materially
different from any future results, performances or achievements that may be
expressed or implied by such forward-looking statements .

diseases controversial

The health insurance industry is now recognizing the
opportunity to better manage patient outcome and healthcare costs with
enhanced compliance.
Additional information about Regeneron and recent news releases
are available on Regeneron's web site at www.

disease treatments

ALR, which plans to begin shipping commercial product in late first quarter
of 2006, will manage initial supply and manufacturing by first targeting
patient population groups: specifically chronic obstructive pulmonary
disease (COPD), mental disorders (schizophrenia, obsessive compulsive
disorder and bipolar), Organ transplantation and HIV/AIDS. Compliance reminder products are now in use by
patients taking medications or treatments for conditions such as
hypertension, high cholesterol, Parkinson, diabetes, organ transplant,
depression , anxiety, asthma, glaucoma and more.

autism sexually

This "real time" identification of
noncompliance allows for timely intervention when deemed necessary.

itself treatments

alrt.

regeneron. Regeneron has therapeutic candidates
for the potential treatment of cancer, eye diseases, rheumatoid
arthritis and other inflammatory diseases, asthma and allergies and
has preclinical programs in other diseases and disorders.regeneron .com

allergies controversial

hypothermia wounds

ALR Technologies Inc. The PC500 reminder product
helps people to be compliant with medication or treatment regimens, and the
monitoring system allows medical service providers to monitor the patient's
compliance with these regimens.

autism itself

respiratory condition

ALR Tech's PC500 Disease Management Reminder Product has been in trial
usage, and now with the addition of the monitoring system the benefit to
patients and healthcare providers is extended.

Regeneron Announces Presentation at Fourth Annual Needham Biotechnology Conference

ulcers diseases

(OTC BB: ALRT),
headquartered in Winston-Salem, NC, announces today they have reached
significant milestones in development of their disease management home
monitoring system.

Business Editors/Health/Medical Writers
BIOWIRE2K
4th Annual Needham Biotechnology Conference

TARRYTOWN, N.

stomach respiratory

PRESS RELEASE ALR Technologies Reaches Product Development Milestones With Their Disease Management Home Monitoring System

disease wounds

Goldberg, Senior Vice President, Finance and
Administration and Chief Financial Officer of Regeneron, will provide
an overview of the Company and its clinical programs. The presentation
is scheduled to be broadcast live on Wednesday, May 25 , 2005 at 2:00
p.

transmitted aids

aids criticisms

The company reports the pilot program for the
monitoring system will commence in September 2005.----Regeneron
Pharmaceuticals, Inc.

stomach trachoma

autism controversies

Murray A.m.
Regeneron is a biopharmaceutical company that discovers, develops,
and intends to commercialize therapeutic medicines for the treatment
of serious medical conditions.